Wilson's disease: Does iron metabolism impact phenotypic presentation?

Liver International

Volumn 32, Issue 5, 2012, Pages 869-870

  Litwin, Tomasz ^a   Gromadzka, Grazyna ^a,b   Członkowska, Anna ^a,b  

^a INSTITUTE OF PSYCHIATRY AND NEUROLOGY   (Poland)

^b MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

IRON;

CERULOPLASMIN BLOOD LEVEL; DEGENERATIVE DISEASE; FERRITIN BLOOD LEVEL; HUMAN; IRON METABOLISM; IRON OVERLOAD; IRON TRANSPORT; LETTER; PHENOTYPE; PSYCHOPATHY; WILSON DISEASE;

FEMALE; HEPATOLENTICULAR DEGENERATION; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; IRON; MALE; MEMBRANE PROTEINS; POLYMORPHISM, GENETIC;

EID: 84859440760     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/j.1478-3231.2012.02756.x     Document Type: Letter

References (8)

1. Pfeiffenberger J, Gotthardt DN, Herrmann T, et al. Iron metabolism and the role of HFE gene polymorphisms in Wilson's disease. Liver Int 2012; 32: 165-70.
2. Bruehlmeier M, Leenders KL, Vontobel P, et al. Increased cerebral iron uptake in Wilson's disease: a 52-Fe-citrate PET study. J Nucl Med 2000; 41: 781-7.
3. Hayashi H, Yano M, Fujita Y, et al. Compound overload of copper and iron in patients with Wilson's disease. Med Mol Morphol 2006; 39: 121-6.
4. Medici V, di Leo V, Lamboglia F, et al. Effect of penicillamine and zinc on iron metabolizm in Wilson's disease. Scand J Gastroenterol 2007; 42: 1495-1500.
5. Roberts E, Schilsky M. Diagnosis and treatment of Wilson's disease an update. Hepatology 2008; 47: 2089-1.
6. Litwin T, Gromadzka G, Czlonkowska A. Gender differences in Wilson's Disease. J Neurol Sci 2012; 312: 31-5.
7. Shulman L. Gender differences in Parkinson's disease. Gend Med 2007; 4: 8-18.
8. Bartzokis G, Tishler T, Lu H, et al. Brain ferritin iron may influence age- and gender-related risks of neurodegeneration. Neurobiol Aging 2007; 28: 414-23.